Endless Summer Vacation, Miley Cyrus

06/23/24 • 77 min

“Endless Summer Vacation” by Miley Cyrus finds the singer achieving her biggest hit with “Flowers” and winning Grammys for the first time in her 17-year career. This week, Keith Montena and Carly Giacoio rewind and discuss how prior career moves and projects like She Is Coming & Plastic Hearts led the singer into a rough commercial territory despite being packed with solid material. With a label switch and new management, the pair investigate how her album rollout surrounding a New Years Eve special and fan-driven narrative surrounding Liam Hemsworth sculpted a huge commercial resurgence. Plus, hear about the album’s singles and creative collaborators through a track-by-track discussion.

Previous Episode

Joanne, Lady Gaga

(Archive Episode, 2023) Lady Gaga's "Joanne" showcases the singer ditching dance-pop in exchange for country and americana. Hear about the creative process behind the 2016 album, as well as the aftermath of 2013's ARTPOP album and how this shift helped the singer recover. The album marked a commercial resurgence for Lady Gaga with performances at The Super Bowl Half Time Show and Coachella, projects like Five Foot Two and A Star Is Born. Plus, discussions on "The Cure" and puzzled fan reception to her new sound. Also, is Lady Gaga releasing a new album this year? Hear about rumored collaborators for her seventh LP, and if Joanne is the best indicator of her next artistic venture.

Next Episode

"Disease", Lady Gaga

Keith Montena is back this week breaking down "Disease" by Lady Gaga, the first taste of the singer's upcoming seventh album. After "Die With A Smile" with Bruno Mars and Joker: Folie á Duex, Lady Gaga returns with the biggest changes to her creative team in nearly 15 years, and an album modeling after dark soundscapes similar to Born This Way. Notably far from 2020's Chromatica. Vinyl Drop discusses pop music with an emphasis on new releases, the artists' creative process, collaborators, and their marketing strategy. I want to hear from you - do you like "Disease"? Did you like the rollout? What should be discussed next?